Galectin-1 expression by regulatory T cells is required for sustained modulation of chronic colitis in regulatory T cell-based therapy

被引：0
|
作者：
Fernandez Perez, Raquel
Alberquilla, Omaira
Sanchez, Rebeca
Martin, Miguel A.
Bueren, Juan A.
Garin, Marina I.
机构：
[1] Ctr Invest Energet Medioambient & Tecnol CIEMAT, Div Hematopoiet Innovat Therapies, Madrid, Spain
[2] Ctr Invest Biomed Red Enfermedades Raras CIBER ER, Madrid, Spain
[3] Inst Invest Sanitaria Fdn Jimenez Diaz IIS FJD, Adv Therapies Mixed Unit, Madrid, Spain
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2021年 / 51卷
关键词：
Adaptive immunity; autoimmunity; cell based therapies; immune regulation and therapy; inflammatory bowel disease; regulatory cells;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-0601
引用
收藏
页码：390 / 390
页数：1
相关论文
共 50 条
  • [21] Regulatory T cells and their potential use in cell based therapy
    Prakken, BJ
    Albani, SSA
    De Kleer, IIM
    Kamphuis, S
    Kuis, W
    Zonneveld, EE
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 27 - +
  • [22] Development of a Novel Regulatory T Cell-Based Therapy for Patients with Rheumatoid Arthritis
    De Vries, Anne-Renee Van der Vuurst
    Hooper, Kathryn
    Graf, Jonathan
    Tuckwell, Katie
    Beilke, Joshua
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4332 - 4334
  • [23] Development of a stable autologous regulatory T cell-based cell therapy for multiple sclerosis
    Baeten, P.
    Hellings, N.
    Broux, B.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A89 - A89
  • [24] Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8+ regulatory T cells
    Cagnoni, Alejandro J.
    Giribaldi, Maria Laura
    Blidner, Ada G.
    Cutine, Anabela M.
    Gatto, Sabrina G.
    Morales, Rosa M.
    Salatino, Mariana
    Abba, Martin C.
    Croci, Diego O.
    Marino, Karina V.
    Rabinovich, Gabriel A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (21)
  • [25] Effect of Galectin-1 on Apoptosis of CD4+ Lymphocytes Differentiated In Vitro Towards Regulatory T Cells
    V. D. Yakushina
    O. A. Vasil’eva
    V. V. Novitskii
    N. V. Andreeva
    E. G. Starikova
    L. A. Tashireva
    T. S. Prokhorenko
    A. P. Zima
    N. V. Ryazantseva
    Bulletin of Experimental Biology and Medicine, 2014, 156 : 669 - 672
  • [26] Effect of Galectin-1 on Apoptosis of CD4+ Lymphocytes Differentiated In Vitro Towards Regulatory T Cells
    Yakushina, V. D.
    Vasil'eva, O. A.
    Novitskii, V. V.
    Andreeva, N. V.
    Starikova, E. G.
    Tashireva, L. A.
    Prokhorenko, T. S.
    Zima, A. P.
    Ryazantseva, N. V.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2014, 156 (05) : 669 - 672
  • [27] Dissecting the Role of Galectin-1 in CD4+CD25+FOXP3+ Regulatory T Cells
    Sanchez, E.
    del Busto, P.
    Bueren, J.
    Garin, M.
    HUMAN GENE THERAPY, 2009, 20 (09) : 1076 - 1077
  • [28] Targeting GALECTIN-1 unleashes antitumor response in colitis-associated colorectal CANCER by shaping the CD8+regulatory t cell compartment
    Cagnoni, Alejandro
    Laura Giribaldi, M.
    Blidner, Ada G.
    Cutine, Ana M.
    Gatto, Sabrina
    Morales, Rosa
    May, Maria
    Salatino, Mariana
    Hockl, Pablo
    Perez Saez, Juan M.
    Abba, Martin
    Croci, Diego
    Marino, Karina
    Rabinovich, Gabriel
    GLYCOBIOLOGY, 2021, 31 (12) : 1707 - 1708
  • [29] Cell-based high throughput screening identified a novel compound that promotes regulatory T cells and prevents autoimmune colitis
    Mao, Rui
    Liu, Haitao
    Yi, Bing
    Purohit, Sharad
    Kuczma, Michal
    Kraj, Piotr
    She, Jin-Xiong
    BIOCHEMICAL PHARMACOLOGY, 2019, 169
  • [30] Clinical Outlook for Type-1 and FOXP3+ T Regulatory Cell-Based Therapy
    Gregori, Silvia
    Passerini, Laura
    Roncarolo, Maria-Grazia
    FRONTIERS IN IMMUNOLOGY, 2015, 6
12345